对《SARS-CoV-2疫苗反应原性分析：按类型、剂量、既往SARS-CoV-2感染的病史、严重程度和近期情况的差异》的勘误
Correction to: An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection.
出版信息
Open Forum Infect Dis. 2022 Aug 9;9(8):ofac412. doi: 10.1093/ofid/ofac412. eCollection 2022 Aug.
Abstract
[This corrects the article DOI: 10.1093/ofid/ofac314.].
摘要
[本文更正了文章DOI：10.1093/ofid/ofac314。]
相似文献
1
Correction to: An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection.
Open Forum Infect Dis. 2022 Aug 9;9(8):ofac412. doi: 10.1093/ofid/ofac412. eCollection 2022 Aug.
2
Correction.
Open Forum Infect Dis. 2024 May 10;11(5):ofae247. doi: 10.1093/ofid/ofae247. eCollection 2024 May.
3
Correction to: SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada.
Open Forum Infect Dis. 2022 Aug 6;9(8):ofac378. doi: 10.1093/ofid/ofac378. eCollection 2022 Aug.
4
Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2.
Vaccines (Basel). 2021 Sep 20;9(9):1047. doi: 10.3390/vaccines9091047.
5
SARS-CoV-2 BNT162b2 vaccine-induced humoral response and reactogenicity in individuals with prior COVID-19 disease.
JCI Insight. 2022 Feb 22;7(4):e155889. doi: 10.1172/jci.insight.155889.
6
COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1). doi: 10.1212/NXI.0000000000001104. Print 2022 Jan.
7
Correction to: SARS-CoV-2 Surface Swabs in Locations With Public Access- Potential for Improved Source Control.
Open Forum Infect Dis. 2022 Oct 31;9(10):ofac566. doi: 10.1093/ofid/ofac566. eCollection 2022 Oct.
8
Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection.
Infection. 2022 Jun;50(3):791-793. doi: 10.1007/s15010-021-01729-z. Epub 2021 Dec 2.
9
Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
PLoS Med. 2023 Jan 6;20(1):e1004159. doi: 10.1371/journal.pmed.1004159. eCollection 2023 Jan.
10
Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy.
Hum Vaccin Immunother. 2021 Dec 2;17(12):4747-4754. doi: 10.1080/21645515.2021.2002639. Epub 2022 Jan 27.
Zotero 插件